Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Older adults losing SNAP benefits in November. Give now to help ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. AARP offers savings & planning resources for all—members also ...
Entera Bio is positioning EB613 as an alternative to injectable anabolic therapies, which despite clinical guidelines recommending their use, remain underutilized due to administration challenges and ...
JERUSALEM - Entera Bio Ltd. (NASDAQ:ENTX), a $105 million market cap biotechnology company with strong recent performance (+27% over the past year), announced new clinical data from its Phase 2 trial ...
(MENAFN- GlobeNewsWire - Nasdaq) Consistency of BMD gains presented at NAMS 2025 demonstrate EB613's efficacy in both young postmenopausal women and in women 10 years post-menopause Data further ...
JERUSALEM, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported new clinical data from a post-hoc ...